Biotechnology Cabinet Unveils Bio-Manufacturing and Biofoundry Initiative
Significant Approval for Biotechnology in India
In a pivotal move for India's biotechnology sector, the Union Cabinet, under the leadership of Prime Minister Narendra Modi, has approved the Bio-RIDE scheme with an impressive outlay of Rs 9,197 crore. This initiative is set to foster innovation and promote bio-entrepreneurship, ultimately positioning India as a central figure in biomanufacturing.
Key Components of the Bio-RIDE Scheme
- Biotechnology Research and Development (R&D)
- Industrial & Entrepreneurship Development (I&ED)
- Biomanufacturing and Biofoundry
During the post-Cabinet press briefing, Union Minister Ashwini Vaishnaw articulated the importance of this initiative in addressing both national and global challenges. "The approval of the Bio-RIDE scheme marks a significant step forward for India’s biotechnology mission," he stated. The initiative aims at enhancing research capabilities and bridging the gap between academic research and industrial applications.
Goals and Focus Areas
The Bio-RIDE scheme merges previous biotechnology umbrella schemes under the Department of Biotechnology (DBT) while introducing new components focused on biomanufacturing and biofoundry. Target areas identified include synthetic biology, biopharmaceuticals, bioenergy, and bioplastics.
Support for Startups and Sustainable Practices
Dubbed as a move to nurture a thriving ecosystem for startups, the Bio-RIDE scheme will offer seed funding, incubation support, and mentorship to budding bio-entrepreneurs. Additionally, a key aspect is its alignment with the Lifestyle for the Environment (LiFE) initiative aimed at climate change mitigation, promoting sustainable practices in biomanufacturing.
Looking to the Future
The ambitious target set by the DBT is to develop a $300-billion bioeconomy by 2030. With the Bio-RIDE initiative, the government is laying down a solid foundation for a prosperous Viksit Bharat 2047, supporting cutting-edge research and fostering talent in the biotechnology sector.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.